probiome Sign in
← Conditions Nervous system Genus-level

Epilepsy

Compared within 1 study that had both: 21 people with epilepsy and 11 healthy people. No genera less common in people with epilepsy, and none more common.

A difference is an association: it doesn’t mean these genera cause, prevent or treat epilepsy. GMrepo reports this group at the genus level only, so these are genera, not species.

Searching opens both lists and shows only matching rows.

Less common in epilepsy · 0

Strongest first, then the biggest gap · Each figure is 10 people Strongest first · Each figure is 10 people

None compared.

More common in epilepsy · 0

Strongest first, then the biggest gap · Each figure is 10 people Strongest first · Each figure is 10 people

None compared.

Where these numbers come from

Studies
Only GMrepo projects that had people with the condition and healthy people, 10 or more of each. Numbers come from those studies, never from pooling.Sampled in China.
How common
The share of people whose sample has any of it, in the people with the condition and in the healthy people of those same studies. Tested within studies (Cochran–Mantel–Haenszel, corrected for testing many microbes); a difference counts when it is clear and meaningful (Cohen’s h of 0.2 or more).
Strength word
Counted by code from how many studies point the same way: Seen again and again (3 or more, none clearly the other way), Seen more than once (2, the majority), Seen once (1, listed last). Where studies disagree, a row isn’t listed.
Each study
Tap a row for every study’s own numbers, and for how much carriers have.
Analysis
Our analysis of GMrepo data. GMrepo on Data sources · Read the rules

Also compared · 36 genera

Compared within studies that had both, but not listed above.

No meaningful difference · 36
PubMed · human studies and reviews first

Recent research

All research on it
  1. Clinical trial Chinese medical journal · 2026
    Akkermansia muciniphila enhances washed microbiota transplantation in the treatment of epilepsy.
    PubMed ↗
  2. Review International review of neurobiology · 2026
    The microbiota-gut-brain axis in epilepsy: Mechanistic insights and emerging probiotic-based therapeutics.
    PubMed ↗
  3. Meta-analysis Reviews in the neurosciences · 2026
    Probiotics and seizure susceptibility in preclinical epilepsy models: mechanistic insights from a systematic review and meta-analysis.
    PubMed ↗
  4. Observational Microbial cell factories · 2025
    The comparison of gut microbiota between different types of epilepsy in children.
    PubMed ↗
  5. Meta-analysis Microbial pathogenesis · 2024
    The alteration of gut microbiota composition in patients with epilepsy: A systematic review and meta-analysis.
    PubMed ↗

Source: PubMed, U.S. National Library of Medicine · 41 linked papers, last 10 years